The FDA has introduced Elsa, an internal AI tool to review safety data, identify labeling issues, and prioritize inspections, ...

The FDA’s clunky launch of Elsa, an AI tool to increase efficiency, has sparked concern from agency employees and outside ...

One of the concerns people have when they hear FDA is using AI in the drug approval process is that many people don't have a ...

The FDA has introduced Elsa, an internal AI tool to review safety data, identify labeling issues, and prioritize inspections, potentially speeding up responses to food safety issues like recalls.

One new tool, named Elsa, is similar to ChatGPT and may help the FDA review safety data, summarize reports and flag which drug or food facilities need inspection, The New York Times reported.

Elsa’s launch also came on the heels of Trump’s 2026 budget proposal (PDF), which recommends cutting the FDA’s budget by 4%, including the cutting of 1,940 staff salaries.

FDA Will Use AI to Approve Drugs and Devices Faster The agency launched a large-language model, dubbed Elsa, just last week to streamline operations.

Elsa may help process up to 500,000 pages of submitted data, the agency said. But there are limits. Some FDA staff said Elsa often gave wrong answers, what experts call “hallucinations”, and ...

The FDA has introduced Elsa, an internal AI tool to review safety data, identify labeling issues, and prioritize inspections, potentially speeding up responses to food safety issues like recalls.